These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27986606)

  • 1. Imaging the neuroplastic effects of ketamine with VBM and the necessity of placebo control.
    Höflich A; Ganger S; Tik M; Hahn A; Kranz GS; Vanicek T; Spies M; Kraus C; Windischberger C; Kasper S; Winkler D; Lanzenberger R
    Neuroimage; 2017 Feb; 147():198-203. PubMed ID: 27986606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine-dependent neuronal activation in healthy volunteers.
    Höflich A; Hahn A; Küblböck M; Kranz GS; Vanicek T; Ganger S; Spies M; Windischberger C; Kasper S; Winkler D; Lanzenberger R
    Brain Struct Funct; 2017 Apr; 222(3):1533-1542. PubMed ID: 27578365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
    Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
    Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of subanesthetic ketamine on intrinsic functional brain connectivity: a placebo-controlled functional magnetic resonance imaging study in healthy male volunteers.
    Niesters M; Khalili-Mahani N; Martini C; Aarts L; van Gerven J; van Buchem MA; Dahan A; Rombouts S
    Anesthesiology; 2012 Oct; 117(4):868-77. PubMed ID: 22890117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: a validation using antipsychotic and glutamatergic agents.
    Doyle OM; De Simoni S; Schwarz AJ; Brittain C; O'Daly OG; Williams SC; Mehta MA
    J Pharmacol Exp Ther; 2013 Apr; 345(1):151-60. PubMed ID: 23370794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers.
    De Simoni S; Schwarz AJ; O'Daly OG; Marquand AF; Brittain C; Gonzales C; Stephenson S; Williams SC; Mehta MA
    Neuroimage; 2013 Jan; 64():75-90. PubMed ID: 23009959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effects of ketamine, risperidone and lamotrigine on resting brain perfusion in healthy human subjects.
    Shcherbinin S; Doyle O; Zelaya FO; de Simoni S; Mehta MA; Schwarz AJ
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4191-204. PubMed ID: 26223493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect.
    Horacek J; Brunovsky M; Novak T; Tislerova B; Palenicek T; Bubenikova-Valesova V; Spaniel F; Koprivova J; Mohr P; Balikova M; Hoschl C
    Psychol Med; 2010 Sep; 40(9):1443-51. PubMed ID: 19995475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gray matter volume of rostral anterior cingulate cortex predicts rapid antidepressant response to ketamine.
    Herrera-Melendez A; Stippl A; Aust S; Scheidegger M; Seifritz E; Heuser-Collier I; Otte C; Bajbouj M; Grimm S; Gärtner M
    Eur Neuropsychopharmacol; 2021 Feb; 43():63-70. PubMed ID: 33309459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine effects on brain function--simultaneous fMRI/EEG during a visual oddball task.
    Musso F; Brinkmeyer J; Ecker D; London MK; Thieme G; Warbrick T; Wittsack HJ; Saleh A; Greb W; de Boer P; Winterer G
    Neuroimage; 2011 Sep; 58(2):508-25. PubMed ID: 21723949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualisation of changes in regional cerebral blood flow (rCBF) produced by ketamine using long TE gradient-echo sequences: preliminary results.
    Burdett NG; Menon DK; Carpenter TA; Jones JG; Hall LD
    Magn Reson Imaging; 1995; 13(4):549-53. PubMed ID: 7674850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A VBM study demonstrating 'apparent' effects of a single dose of medication on T1-weighted MRIs.
    Franklin TR; Wang Z; Shin J; Jagannathan K; Suh JJ; Detre JA; O'Brien CP; Childress AR
    Brain Struct Funct; 2013 Jan; 218(1):97-104. PubMed ID: 22302433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.
    Downey D; Dutta A; McKie S; Dawson GR; Dourish CT; Craig K; Smith MA; McCarthy DJ; Harmer CJ; Goodwin GM; Williams S; Deakin JF
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):994-1003. PubMed ID: 27133029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
    Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
    Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically.
    Holcomb HH; Lahti AC; Medoff DR; Weiler M; Tamminga CA
    Neuropsychopharmacology; 2001 Aug; 25(2):165-72. PubMed ID: 11425500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permutation and parametric tests for effect sizes in voxel-based morphometry of gray matter volume in brain structural MRI.
    Dickie DA; Mikhael S; Job DE; Wardlaw JM; Laidlaw DH; Bastin ME
    Magn Reson Imaging; 2015 Dec; 33(10):1299-1305. PubMed ID: 26253778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-Ketamine-Induced NMDA Receptor Blockade during Natural Speech Production and Its Implications for Formal Thought Disorder in Schizophrenia: A Pharmaco-fMRI Study.
    Nagels A; Cabanis M; Oppel A; Kirner-Veselinovic A; Schales C; Kircher T
    Neuropsychopharmacology; 2018 May; 43(6):1324-1333. PubMed ID: 29105665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General and emotion-specific neural effects of ketamine during emotional memory formation.
    Becker B; Steffens M; Zhao Z; Kendrick KM; Neumann C; Weber B; Schultz J; Mehta MA; Ettinger U; Hurlemann R
    Neuroimage; 2017 Apr; 150():308-317. PubMed ID: 28232170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans.
    Ilkjaer S; Petersen KL; Brennum J; Wernberg M; Dahl JB
    Br J Anaesth; 1996 Jun; 76(6):829-34. PubMed ID: 8679358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.
    Krystal JH; D'Souza DC; Karper LP; Bennett A; Abi-Dargham A; Abi-Saab D; Cassello K; Bowers MB; Vegso S; Heninger GR; Charney DS
    Psychopharmacology (Berl); 1999 Jul; 145(2):193-204. PubMed ID: 10463321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.